體外受精（IVF）市場規模、佔有率和成長分析（按產品類型、產品類型、設備、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，體外受精 (IVF) 市場規模將達到 290.5 億美元，到 2025 年將成長至 314.9 億美元，到 2033 年將成長至 600.4 億美元，在預測期（2026-2033 年）內複合成長率為 8.4%。

全球體外受精（IVF）市場涵蓋了體外受精這項輔助生殖技術，可在體外實現受精，並被廣泛接受為不孕夫婦提供解決方案。其關鍵步驟包括卵巢刺激、取卵、受精和胚胎移植，這些步驟均針對自然受孕困難的患者量身定做。由於生活方式和健康問題導致全球不孕不育率不斷上升，越來越多的夫婦選擇體外受精來建立家庭。技術進步（包括改進的實驗室技術和基因檢測）提高了成功率，並吸引了更多尋求可靠治療的患者。此外，發展中國家對體外受精的認知不斷提高，為透過建立體外受精診所來拓展市場提供了巨大的機會。持續的技術進步為不孕夫婦的求子之路帶來了希望，幫助他們應對心理和生理上的挑戰。

體外受精市場成長要素

體外受精（IVF）市場正經歷顯著成長，這主要得益於生殖技術的不斷進步，這些進步改進了IVF流程。諸如延時成像系統等創新技術能夠對胚胎發育進行持續監測，從而顯著最佳化胚胎選擇過程並提高成功率。這些技術突破不僅最佳化了受孕成功率，也吸引了越來越多尋求不孕症治療的個人和夫婦。隨著人們對這些先進技術的了解不斷加深，越來越多的人選擇IVF治療，這進一步推動了市場需求，並支持對尖端生殖技術研發的持續投資。

體外受精市場的限制

試管嬰兒治療的高昂費用對許多尋求不孕症治療的個人和夫婦來說構成了一大障礙。藥物費用、檢查費用以及可能需要多次治療週期所帶來的經濟負擔可能非常沉重。因此，對於那些資金不足或缺乏適當保險的人來說，試管嬰兒治療可能遙不可及。這種經濟限制不僅使相當一部分人無法獲得治療，還會增加面臨不孕症挑戰者的壓力和心理負擔。消除這些經濟障礙對於擴大試管嬰兒治療的覆蓋範圍至關重要。

體外受精市場趨勢

體外受精（IVF）市場正經歷基因檢測技術，特別是胚胎著床前基因檢測（PGT）的顯著融合趨勢。這一趨勢反映出準父母對更先進的生殖健康方案的需求日益成長，旨在提高懷孕成功率並降低兒童遺傳疾病的風險。隨著夫妻尋求最佳化IVF結果，PGT及類似技術的應用預計將會擴大，從而推動創新並創造新的市場機會。這種對基因篩檢日益成長的關注，與以個人化醫療和強化生殖健康解決方案為重點的更廣泛的醫療保健舉措不謀而合。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析

全球體外受精（IVF）市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 新捐贈者
• 新鮮非捐贈者
• 冷凍捐贈者
• 冷凍非捐贈者

全球體外受精（IVF）市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 裝置
  • 精子分析系統
  • 影像系統
  • 卵子吸泵
  • 微型機械手臂系統
  • 培養箱
  • 氣體分析儀
  • 雷射系統
  • 冷凍保存系統
  • 精子分離裝置
  • 試管嬰兒診所
  • 隔振台
  • 觀測系統
  • 其他設備
• 試劑和介質
  • 冷凍保存介質
  • 胚胎培養基
  • 卵子處理培養基
  • 精子處理培養基
• 配件

全球體外受精（IVF）市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 傳統體外受精
• 體外受精（IVF）合併卵胞漿內單一精子注射（ICSI）技術
• 利用捐贈卵子進行體外受精
• 其他

全球體外受精（IVF）市場規模（依設備及複合年成長率分類）（2026-2033 年）

• 培養基
• 免洗設備
• 資本設備

全球體外受精（IVF）市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 不孕不育診所
• 手術中心
• 醫院
• 研究所

全球體外受精（IVF）市場規模（依地區分類）及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Ferring Pharmaceuticals（Switzerland）
• Merck KGaA（Germany）
• Cook Medical（USA）
• Vitrolife AB（Sweden）
• CooperSurgical, Inc.（USA）
• Ovascience, Inc.（USA）
• Irvine Scientific（USA）
• Genea Limited（Australia）
• Origio A/S（Denmark）
• Thermo Fisher Scientific Inc.（USA）
• Esco Medical ApS（Denmark）
• Nidacon International AB（Sweden）
• Boston IVF（USA）
• Virtus Health（Australia）
• Bloom Fertility Centre（India）
• Rainbow IVF（India）
• IVI RMA Global（Spain）
• CHA Healthcare（South Korea）
• Reproductive Medicine Associates of New Jersey（RMANJ）（USA）
• TSLC Corporation（Japan）

結論與建議

In Vitro Fertilization Market size was valued at USD 29.05 Billion in 2024 and is poised to grow from USD 31.49 Billion in 2025 to USD 60.04 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global In Vitro Fertilization (IVF) market encompasses assisted reproductive technology procedures that facilitate fertilization outside the human body, gaining widespread acceptance as a solution for couples experiencing infertility. Key procedures-ovarian stimulation, egg retrieval, fertilization, and embryo transfer-are tailored for individuals when natural conception is challenging. As global infertility rates rise due to lifestyle factors and health issues, couples increasingly turn to IVF for family building. Technological advancements, including improved laboratory techniques and genetic testing, enhance success rates, attracting more individuals seeking reliable treatments. Additionally, growing awareness in developing regions provides significant opportunities for market expansion through the establishment of IVF clinics. Continuous evolution in techniques offers hope for couples on their fertility journeys, addressing both emotional and physical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

In Vitro Fertilization Market Segments Analysis

Global In Vitro Fertilization Market is segmented by Product Type, Product, Type, Instrument, End User and region. Based on Product Type, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor and Frozen Non-Donor. Based on Product, the market is segmented into Equipment, Reagents & Media and Accessories. Based on Type, the market is segmented into Conventional IVF, IVF with ICSI, IVF with Donar Eggs and Others. Based on Instrument, the market is segmented into Culture Media, Disposable Devices and Capital Equipment. Based on End User, the market is segmented into Fertility Clinics, Surgical Centers, Hospitals and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the In Vitro Fertilization Market

The In Vitro Fertilization market is experiencing substantial growth, fueled by ongoing advancements in reproductive technologies that enhance IVF procedures. Innovations such as time-lapse imaging systems facilitate continuous observation of embryo development, which significantly improves selection processes and increases success rates. These technological breakthroughs not only optimize the chances of successful pregnancies but also appeal to a growing number of individuals and couples seeking fertility solutions. As awareness of these advanced methods spreads, more people are opting for IVF treatments, further driving market demand and encouraging continued investment in the development of cutting-edge reproductive technologies.

Restraints in the In Vitro Fertilization Market

The high costs associated with In Vitro Fertilization treatments present a considerable barrier for many individuals and couples seeking fertility solutions. The financial burden stemming from medications, laboratory procedures, and the potential need for multiple treatment cycles can be overwhelming. As a result, IVF may become unattainable for those who lack sufficient financial resources or adequate insurance coverage. This economic constraint not only limits access for a significant segment of the population but may also lead to increased stress and emotional strain for those navigating the challenges of infertility. Addressing these financial obstacles is crucial for expanding access to IVF.

Market Trends of the In Vitro Fertilization Market

The In Vitro Fertilization market is experiencing a notable shift towards the integration of genetic testing techniques, particularly preimplantation genetic testing (PGT). This trend reflects an increasing demand among prospective parents for enhanced reproductive options aimed at improving the likelihood of successful pregnancies and minimizing the risk of genetic disorders in children. As couples seek to optimize their IVF outcomes, the adoption of PGT and similar technologies is expected to expand, driving innovation and creating new market opportunities. This growing emphasis on genetic screening aligns with broader healthcare initiatives focused on personalized medicine and enhanced reproductive health solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global In Vitro Fertilization Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

Global In Vitro Fertilization Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other Equipments
• Reagents & Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Accessories

Global In Vitro Fertilization Market Size by Type & CAGR (2026-2033)

• Market Overview
• Conventional IVF
• IVF with ICSI
• IVF with Donar Eggs
• Others

Global In Vitro Fertilization Market Size by Instrument & CAGR (2026-2033)

• Market Overview
• Culture Media
• Disposable Devices
• Capital Equipment

Global In Vitro Fertilization Market Size by End User & CAGR (2026-2033)

• Market Overview
• Fertility Clinics
• Surgical Centers
• Hospitals
• Research Institutes

Global In Vitro Fertilization Market Size & CAGR (2026-2033)

• North America (Product Type, Product, Type, Instrument, End User)
  • US
  • Canada
• Europe (Product Type, Product, Type, Instrument, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Product, Type, Instrument, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Product, Type, Instrument, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Product, Type, Instrument, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ovascience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Irvine Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Origio A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidacon International AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston IVF (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virtus Health (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom Fertility Centre (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rainbow IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVI RMA Global (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CHA Healthcare (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reproductive Medicine Associates of New Jersey (RMANJ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSLC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations